Insider trades
Chris A. Rallis, Director of Fennec Pharmaceuticals FENC, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $75.2K. The latest trade was on 06/10.
Chris A. Rallis
Director
- Company
- Fennec Pharmaceuticals FENC
- First filing
- 23/03/03
- Trades
- 51 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$75.2K
- Last trade
- 06/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/11 | 05/12 | 8,346 sh | $7.04 | $58,755.84 | −11.7% | |
| Open-market sale10b5-1 plan | 25/10/10 | 25/10/14 | 1,775 sh | $9.24 | $16,401 | −3.0% | |
| Open-market sale10b5-1 plan | 25/07/07 | 25/07/07 | 1,119 sh | $8.71 | $9,746.49 | −2.0% | |
| Open-market sale10b5-1 plan | 25/04/11 | 25/04/11 | 1,409 sh | $4.95 | $6,974.55 | −2.6% | |
| Open-market sale10b5-1 plan | 25/02/14 | 25/02/14 | 1,186 sh | $6.82 | $8,088.52 | −2.2% | |
| Open-market sale10b5-1 plan | 24/12/02 | 24/12/02 | 6,409 sh | $6.14 | $39,351.26 | −10.9% | |
| Open-market sale10b5-1 plan | 24/10/08 | 24/10/10 | 1,406 sh | $4.53 | $6,369.18 | −2.8% | |
| Open-market sale10b5-1 plan | 24/07/05 | 24/07/08 | 1,173 sh | $6.03 | $7,073.19 | −2.5% | |
| Open-market sale10b5-1 plan | 24/04/15 | 24/04/15 | 800 sh | $10.45 | $8,360 | −1.8% | |
| Open-market sale10b5-1 plan | 24/03/26 | 24/03/27 | 2,114 sh | $10.97 | $23,190.58 | −4.9% | |
| Open-market sale10b5-1 plan | 23/12/26 | 23/12/28 | 1,390 sh | $10.90 | $15,151 | −3.0% | |
| Open-market sale10b5-1 plan | 23/11/20 | 23/11/20 | 269 sh | $8.25 | $2,219.25 | −0.6% | |
| Open-market sale10b5-1 plan | 23/08/18 | 23/08/18 | 673 sh | $7.85 | $5,283.05 | −1.5% | |
| Open-market sale10b5-1 plan | 23/07/24 | 23/07/24 | 6,796 sh | $8.17 | $55,523.32 | −13.4% | |
| Open-market sale10b5-1 plan | 23/07/06 | 23/07/06 | 2,207 sh | $8.47 | $18,693.29 | −7.1% | |
FENC | Open-market sale10b5-1 plan | 23/05/19 | 23/05/19 | 1,758 sh2 trades | $7.36avg. | $12,938.88 | −5.4% |